2018
DOI: 10.1007/s11243-018-0262-0
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis of copper(II) and zinc(II) complexes with chalcone–thiosemicarbazone hybrid ligands: X-ray crystallography, spectroscopy and yeast activity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(2 citation statements)
references
References 31 publications
0
2
0
Order By: Relevance
“…The redox properties of chelating drugs and their metal complexes, which are used to treat various diseases, are one of the central factors in their therapeutic activity and a However, this mechanism, which includes lipid peroxidation in membranes, is not characteristic of all compounds of this class. Thus, studies have shown that the complexes of 2-((E)-3-(4-chlorophenyl)-1-phenylallylidene)-N-phenyl-hydrazinecarbothioamide (HL1) and 2-((E)-3-(4-cyanophenyl)-1-phenylallylidene)-N-phenyl-hydrazinecarbothioamide (HL4) (Figure 9) with copper have an antiproliferative effect in experiments on S. cerevisiae cells [225]. However, difference in the mechanism of action has been proposed where, in the case of HL4, the effects are on proliferation by preventing the formation of viable daughter cells, whereas, in the case of HL1, the effects are related to the induction of lipid peroxidation in the plasma membrane [225].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The redox properties of chelating drugs and their metal complexes, which are used to treat various diseases, are one of the central factors in their therapeutic activity and a However, this mechanism, which includes lipid peroxidation in membranes, is not characteristic of all compounds of this class. Thus, studies have shown that the complexes of 2-((E)-3-(4-chlorophenyl)-1-phenylallylidene)-N-phenyl-hydrazinecarbothioamide (HL1) and 2-((E)-3-(4-cyanophenyl)-1-phenylallylidene)-N-phenyl-hydrazinecarbothioamide (HL4) (Figure 9) with copper have an antiproliferative effect in experiments on S. cerevisiae cells [225]. However, difference in the mechanism of action has been proposed where, in the case of HL4, the effects are on proliferation by preventing the formation of viable daughter cells, whereas, in the case of HL1, the effects are related to the induction of lipid peroxidation in the plasma membrane [225].…”
Section: Discussionmentioning
confidence: 99%
“…Thus, studies have shown that the complexes of 2-((E)-3-(4-chlorophenyl)-1-phenylallylidene)-N-phenyl-hydrazinecarbothioamide (HL1) and 2-((E)-3-(4-cyanophenyl)-1-phenylallylidene)-N-phenyl-hydrazinecarbothioamide (HL4) (Figure 9) with copper have an antiproliferative effect in experiments on S. cerevisiae cells [225]. However, difference in the mechanism of action has been proposed where, in the case of HL4, the effects are on proliferation by preventing the formation of viable daughter cells, whereas, in the case of HL1, the effects are related to the induction of lipid peroxidation in the plasma membrane [225]. It has also been shown that complex formation with copper leads to an increase in the selectivity of the TSCs against melanoma cells.…”
Section: Discussionmentioning
confidence: 99%